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Abstract
Background: One explanation for the persistence of schizophrenia despite the reduced fertility of patients is
that it is a by-product of recent human evolution. This hypothesis is supported by evidence suggesting that recently-
evolved genomic regions in humans are involved in the genetic risk for schizophrenia. Using summary statistics from
genome-wide association studies (GWAS) of schizophrenia and 11 other phenotypes, we tested for enrichment of
association with GWAS traits in regions that have undergone methylation changes in the human lineage compared to
Neanderthals and Denisovans, i.e. human-specific differentially methylated regions (DMRs). We used analytical tools
that evaluate polygenic enrichment of a subset of genomic variants against all variants.
Results: Schizophrenia was the only trait in which DMR SNPs showed clear enrichment of association that passed the
genome-wide significance threshold. The enrichment was not observed for Neanderthal or Denisovan DMRs.
The enrichment seen in human DMRs is comparable to that for genomic regions tagged by Neanderthal Selective Sweep
markers, and stronger than that for Human Accelerated Regions. The enrichment survives multiple testing performed
through permutation (n = 10,000) and bootstrapping (n = 5000) in INRICH (p < 0.01). Some enrichment of association
with height was observed at the gene level.
Conclusions: Regions where DNA methylation modifications have changed during recent human evolution
show enrichment of association with schizophrenia and possibly with height. Our study further supports the
hypothesis that genetic variants conferring risk of schizophrenia co-occur in genomic regions that have changed as the
human species evolved. Since methylation is an epigenetic mark, potentially mediated by environmental changes, our
results also suggest that interaction with the environment might have contributed to that association.
Keywords: Differentially methylated regions, Schizophrenia, Evolution, Epigenetics, Height, Neanderthal selective
sweep score, Human accelerated regions
Background
Schizophrenia is a psychiatric disorder that has been re-
ported throughout human history, possibly as far back as
5000 years [1, 2]. Family, twin and adoption studies estimate
that schizophrenia has a high heritability of 60–90% [3–6].
Today, schizophrenia is estimated to have a prevalence of
1%. It is associated with reduced fertility and increased mor-
tality [7–11], and its persistence despite this heavy burden is
paradoxical. Power et al. [11] leveraged Swedish registry data
to demonstrate the reduced fecundity of patients with
schizophrenia, despite the novel finding that sisters of indi-
viduals with schizophrenia had higher fitness than controls.
They henceforth suggested hitherto unknown mechanisms
for persistence of the disease. One explanation for this per-
sistence is that evolution has indirectly selected the disease
instead of eliminating it - the disease may co-segregate with
creativity and intellectual prowess, providing selective ad-
vantages to the kin of affected individuals [9, 12]. Crow first
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argued that language and psychosis may have common ori-
gins, which could explain the persistence of schizophrenia
in human populations [12, 13]. This evolutionary hypothesis
of the origins of schizophrenia can now be tested, thanks to
the identification of genetic factors implicated in schizophre-
nia [14–16] and the availability of datasets that reflect recent
genomic evolution in humans [17–19].
Large genome-wide association studies (GWAS) have
identified thousands of variants that are associated with
schizophrenia [14–16] but our mechanistic understand-
ing of the candidate variants is poor. One approach to
investigating the function of schizophrenia-associated
variants is comparative genomics, which investigates the
evolutionary relevance of certain genomic regions [20].
This field has introduced new datasets to test disease or-
igins in humans, including Human Accelerated Regions
(HARs) and Neanderthal Selective Sweep (NSS) scores
[18, 19]. HARs are genomic regions that are highly con-
served in non-human species, but have undergone rapid
sequence change in the human lineage [20–24]. Xu et al.
[18] showed that genes near HARs are enriched for as-
sociation with schizophrenia. Neanderthals were homi-
nids that co-existed and even bred with modern humans
[25, 26]. Comparison of Neanderthal and human gen-
ome sequences [27, 28] has revealed genomic regions
that have experienced a selective sweep in modern
humans, presumably following a favorable mutation
[28]. Negative NSS scores can be used to pinpoint muta-
tions (usually single nucleotide changes) that were posi-
tively selected in humans as they diverged from
Neanderthals. Srinivasan et al. [19] found that genomic
regions tagged by negative NSS scores show enrichment
of association with schizophrenia.
Using specific interpretation of genome sequencing
in two recently extinct hominids, Neanderthals and
Denisovans, Gokhman et al. [29] mapped genome-
wide methylation levels (i.e. the methylome) and com-
pared them to modern humans. While 99% of the
methylation maps were identical in the three homi-
nids, nearly 2000 differentially methylated regions
(DMRs) were identified, which give the first clues
about the role of epigenomic evolution in generating
anthropometric differences between modern humans
and their ancient cousins [29]. These DMRs provide a
dataset of evolutionary annotations complementary to
pre-existing datasets. Unlike HARs and NSS scores,
which are based on DNA sequence changes, DMRs
provide information on the evolution of epigenomes.
Since epigenomes can act as an interface with the en-
vironment [30, 31], these datasets provide the opportun-
ity to investigate environmentally driven evolutionary
changes. Keeping in mind the evolutionary hypothesis
for schizophrenia proposed by Crow, we thus exam-
ined if these evolutionary DMRs are enriched for
association with schizophrenia. We also examined a
range of human traits to compare the possible enrich-
ment in other traits. Using previously published meth-
odologies [19, 32, 33] and publicly available GWAS
datasets we systematically analyzed twelve diverse pheno-
types to investigate the potential role of regions suscep-
tible to epigenetic variation in the emergence of specific
traits in the human lineage.
Results
SNPs in human-specific DMRs are enriched for association
with schizophrenia.
The genomic locations of human-specific DMRs were
obtained from data published by Gokhman et al. [29]
(see Methods for full details). GWAS summary statis-
tics for 12 common traits were obtained from pub-
lished datasets: schizophrenia [14], bipolar disorder
(BPD) [34], attention deficit hyperactivity disorder
(ADHD) [35], rheumatoid arthritis [36], high density
lipoprotein [37], low density lipoprotein [37], triglyc-
erides [37], total cholesterol [37], systolic blood pres-
sure [38], diastolic blood pressure [38], body mass
index [39], and height [40]. The GWAS datasets are
summarized in Additional file 1, Table S1. For each
trait, we generated a list of single nucleotide polymor-
phisms (SNPs) within DMRs (positional annotation)
and a list of SNPs in linkage disequilibrium (LD-based an-
notation) with markers within DMRs (Additional file 1,
Table S1).
We used quantile-quantile (QQ) plots as described
by Schork et al. [32] to test whether the DMR SNPs
are enriched for association with the GWAS trait
compared to the complete set of SNPs (see Methods
for additional details). In such plots the baseline is
the null line of no difference between expected distri-
bution of p-values and observed p-values. Deviation
of the observed data distributions from the expected
data distribution indicates the presence of true associ-
ations. When the p-values for a set of selected
markers show greater leftwards deflection, they are
enriched for association compared to the overall
GWAS set. For the schizophrenia GWAS, enrichment
was observed both for SNPs in LD with markers in
DMRs (Fig. 1, Additional file 1: Fig. S1) and for SNPs
located within DMRs (Fig. 2). Although there was a
slight leftward deflection in the higher p-values
(smaller negative log10 of p-values) in some other
traits (e.g. height; Fig. 1, Additional file 2: Figure S1),
the observed enrichment only crosses the genome-
wide significance level of 5 × 10− 8 for the schizophrenia
SNPs. The enrichment of disease-associated markers in
DMRs is thus specific to schizophrenia and is independent
of LD.
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Human-specific DMR enrichment in schizophrenia is
independent of the MHC region, other genomic
annotations and total markers genotyped
The Major histocompatibility complex (MHC) region
harbors several significant schizophrenia markers and
could potentially bias our results because of long-range
LD. The QQ plots show that the enrichment remains
when the MHC is excluded (Fig. 1) or included (Fig. 2).
The schizophrenia GWAS had the highest density of
markers genotyped (~ 9.4 million) and thus had the most
Fig. 1 Enrichment of DMR SNPs across SCZ, BPD, BMI and Height. Quantile-Quantile (QQ) plots of GWAS SNPs for Schizophrenia (SCZ) with the
extended MHC region masked (chr6: 25-35 Mb), Bipolar Disorder (BPD), Body Mass Index (BMI) and Height. The X-axis shows expected -log10 p-
values under the null hypothesis. The Y-axis shows actual observed -log10 p-values. The values for all GWAS SNPs are plotted in pink while the
values for SNPs in linkage disequilibrium (LD) with DMRs are plotted in blue. Leftwards deflections from the null line (grey diagonal line) indicate
enrichment of true signals - the greater the leftward deflection, the stronger the enrichment. Genomic correction was performed on all SNPs with
global lambda
Fig. 2 Comparison of enrichment of association with schizophrenia for SNPs within Human, Neanderthal and Denisovan DMRs. The figure shows
QQ plots for all schizophrenia (SCZ) GWAS SNPs in green while SNPs within the species-specific DMRs are plotted in red. The location of the MHC
is unknown in Neanderthal and Denisovan genomes, so the MHC region was not masked in the human genome
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SNPs in DMR regions (Additional file 1: Table S1),
which could artificially inflate the enrichment. We nor-
malized the total number of DMR SNPs with the total
number of SNPs genotyped in each GWAS and found
that the proportion of SNPs in DMRs is nearly identical
for all traits (Additional file 1: Figure S3). To further
eliminate the possibility that the enrichment is due to
variation in the number of markers analyzed, we ex-
tracted ~ 2.4 million SNPs that were common across the
twelve GWAS. Although not as strong as with the full
set, the deflection observed for the schizophrenia GWAS
remains higher than any other trait (Additional file 1:
Figure S1), indicating the presence of significant disease
markers in DMRs. These validations point to a true en-
richment of association of the DMR SNPs with schizo-
phrenia that is independent of the number of markers in
a GWAS. It should be noted that we cannot rule out en-
richment in the ADHD and BPD GWAS, because they
are lacking in power (Additional file 1: Figure S1).
Additionally, we considered the distribution of
schizophrenia-associated SNPs based on genomic anno-
tations of 5′ untranslated regions (5’UTRs), Exons, In-
trons and 3′ untranslated regions (3’UTRs) [32].
Contrary to previously published findings [32], the en-
richment was highest for intronic SNPs and lowest for
5’UTR SNPs (Additional file 1: Figure S4).
Only human-specific DMRs are enriched for association
with schizophrenia
Next, we used QQ plots to test whether markers located
in the Neanderthal- and Denisovan-specific DMRs are
enriched for association with schizophrenia. Coordinates
for these DMRs were obtained from data published by
Gokhman et al., 2014 [29] (see Methods for details).
Since we do not know the precise coordinates of the
MHC for Neanderthals and Denisovans, the analysis for
human DMRs included the MHC region. No enrichment
was observed for Neanderthal or Denisovan DMRs (Fig.
2). It should be noted that this approach may not be ap-
propriate for testing Neanderthal- and Denisovan-
specific DMRs since (a) the schizophrenia GWAS was
conducted in humans; (b) SNP and LD information is
available only for humans; (c) the three hominids had
variable number of DMRs, which affected the number of
SNPs captured via positional annotation.
Comparison of human DMRs with other evolutionary
annotations
We compared the enrichment observed for the human
DMRs with the enrichment previously reported for NSS
markers and HARs [18, 19] (see Methods for details).
We first compared the enrichment via QQ plots and find
that the enrichment of human DMRs in schizophrenia is
comparable to that observed for NSS markers and far
greater than that observed for HARs (Fig. 3).
In these analyses, it was important to check the extent
of overlap of markers (SNPs) annotated to various gen-
omic regions of DMRs, NSS markers and HARs.
Reassuringly, the various evolutionary annotations do
not share the same group of markers, indicating that we
did not test the same regions or SNPs (Additional file 1:
Figure S2). The overlap between NSS markers and DMR
markers involved less than 0.5% of all NSS markers and
less than 0.2% of all DMR markers (Additional file 1:
Figure S2). The SNPs in the DMRs thus represent a dif-
ferent group of markers that have not been annotated or
analyzed previously from an evolutionary standpoint
(Additional file 2, Additional file 3).
Statistically-significant enrichment exists for human DMRs
To determine the statistical significance of the DMR en-
richment in schizophrenia, we utilized the INRICH soft-
ware pipeline. INRICH is a pathway analysis tool for
GWAS, designed for detecting enriched association sig-
nals of LD-independent genomic regions within bio-
logically relevant gene sets (in our case genes which
contain DMRs). It performs permutation and bootstrap-
ping procedures to determine the significance of associ-
ation of markers in LD intervals while maintaining the
SNP density and gene density of the original intervals
[33]. INRICH confirmed significant (p < 0.05) enrich-
ment of association for human DMRs with schizophre-
nia after correcting for multiple testing through
bootstrapping at most p-value thresholds of LD inter-
vals. Additionally, INRICH independently verified the
previously reported enrichment of NSS markers with
schizophrenia [19] (Fig. 4). Furthermore, INRICH identi-
fied gene-level enrichment of association for DMRs
with height (Additional file 1: Figure S5), while at the
SNP level the enrichment in height was seen only for
smaller effects, i.e. the enrichment did not remain
below p < 10− 8.
Pathway analysis
We utilized Ingenuity Pathway Analysis (IPA) to analyze
DMR SNPs that show enrichment of association with
schizophrenia (for details of the genes analyzed, please
refer to the ‘Pathway analysis’ section in the Methods).
We found ‘CREB signaling in neurons’ and ‘Synaptic
long term potentiation’ amongst the top canonical path-
ways when analyzing pathways overrepresented in ner-
vous system. Additionally, under physiological systems,
‘Nervous system development and function’ is also
enriched (Additional file 1: Table S2). We repeated the
same analysis for NSS markers as they also show enrich-
ment of association with schizophrenia. ‘CREB signaling
in neurons’ was also amongst the top canonical pathways
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Fig. 3 Comparison of enrichment of association with schizophrenia for SNPs in LD with various evolutionary annotations. QQ plots for association
with schizophrenia (SCZ) of SNPs in different evolutionary datasets (DMRs - red, NSS - orange, Primate HARs (pHARs) - blue, HARs - magenta,
PARs - dark green) versus schizophrenia GWAS with all SNPs (light green). SNPs are corrected for genomic inflation using global lambda
Fig. 4 INRICH test for enrichment of association of DMR, NSS and Accelerated Region gene sets. Corrected p-values based on performing
multiple testing with bootstrapping 5000 times, with p = 0.1 as threshold. The various evolutionary annotations compared are: DMR, human-specific
DMRs; NSS, Neanderthal Selective Sweep; HAR, mammalian conserved regions that are accelerated in humans; PAR, mammalian conserved regions
that are accelerated in primates; and PrimateHAR (pHAR), primate-conserved regions that are accelerated in humans
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for enriched NSS markers (Additional file 1: Table S4).
Additionally, we repeated the analyses with all organ sys-
tems and even then, ‘CREB signaling in neurons’ and ‘Syn-
aptic long term potentiation’ emerged amongst the top
canonical pathways for both enriched DMRs (Add-
itional file 1: Table S3) and enriched NSS (Additional file 1:
Table S5). This is an interesting result since there is very
little marker overlap between the DMR and NSS SNPs
(Additional file 1: Figure S2). Interestingly, genes contain-
ing enriched DMRs are also overrepresented in ‘Hair and
skin development’ when considering all organ systems
(Additional file 1: Table S3). This may suggest potential
gene-by-environment interactions, modulated by methyla-
tion variation over human evolution (see Discussion
below).
Discussion
Our results suggest that SNPs in regions of the human
genome that have undergone recent changes in DNA
methylation status are enriched for association with
schizophrenia, and to a lesser extent with height.
Amongst all the traits analyzed, the enrichment ob-
served in QQ plots was strongest for schizophrenia and
passed the genome-wide significance threshold of 5 ×
10− 8 when the MHC was both excluded (Fig. 1) and
included (Fig. 2). INRICH analysis confirms significant
enrichment (p < 0.01) in human DMRs that survived
multiple testing through bootstrapping (Fig. 4) for
association with schizophrenia, and also suggests a
possible effect on height (Additional file 1: Figure S5).
Xu et al. [18] and Srinivasan et al. [19] respectively
demonstrated that variants located in HARs and in
regions containing NSS markers were enriched for asso-
ciation with schizophrenia. In our study, we compared
the evolutionary enrichments of schizophrenia risk vari-
ants in DMRs, NSS markers and HARs. We validate the
results of Srinivasan et al. [19] (Fig. 3 and Fig. 4). HARs
do not show enrichment of disease markers by QQ plots
and INRICH, unlike NSS markers and DMRs (Fig. 3 and
Fig. 4). This difference with the report of Xu et al. could
be due to a different freeze of the gene database used; it
could also be because Xu et al. used a more stringent
Hardy-Weinberg equilibrium (HWE) threshold to filter
out markers from the schizophrenia GWAS [14], a step
we could not replicate as the genotype data are not pub-
licly available. We used the publicly available schizophre-
nia dataset that has a HWE p-value > 10− 6 in controls
and p-value > 10− 10 in cases [14]. Interestingly, all the
evolutionary annotations (DMRs, NSS markers and
HARs) cover different sections of the genome with very
little overlap between them (Additional file 1: Figure S2).
Between the three evolutionary annotations, nearly
70,000 SNPs occur around regions with evolutionary
significance (Additional file 1: Figure S2). Our results
supply a wealth of information on genomic regions that
are important for the evolution of humans and are also
enriched for schizophrenia risk variants (NSS markers
and DMRs, Additional file 3). In addition, our study
provides genetic support from two independent datasets
that regions which differ between modern and ancient
hominids could be implicated in the development of
schizophrenia. An interesting hypothesis to consider is
the possibility that methylation patterns are potentially
driven by the genomic sequence underneath. This
hypothesis is supported by preliminary findings
presented at the recently concluded World Psychiatrics
Genetics Congress [41]. As such it is possible that the
human specific DMRs analyzed here represent regions
of the human genome where the underlying sequence
might have diverged from Neanderthals and Denisovans.
This hypothesis may be partially true as Gokhman et al.
[29] observed that some, but not all of the methylation
changes were indeed driven by sequence changes. On
the other hand, there also exist metastable epialleles
where there are methylation differences in genetically
identical individuals [42]. As such, this would suggest
that not all methylation differences are driven by the
underlying genomic sequence alone. We did not test
whether the schizophrenia markers are human-specific
or not and therefore should be investigated in future
research.
Neanderthal- or Denisovan-specific DMRs showed no
enrichment of association (Fig. 2). This suggests that
SNPs conferring vulnerability to schizophrenia occur in
genomic regions whose methylation levels were altered
in the modern human lineage but not in the ancestral
lineages. It is possible that the evolutionary changes
driving the variation in methylation status could also
have made the human lineage more vulnerable to
schizophrenia. A caveat to this result is that the LD
structure in archaic genomes is unknown, so we cannot
test LD-based enrichment in Neanderthal or Denisovan
genomes. Our inter-lineage analyses with enrichment
plots were thus restricted to SNPs occurring exclusively
within DMRs. The other limitation to this comparative
approach is that the GWAS data is specific to modern
humans.
In previous studies [32], it was reported that 5’UTRs
are the functional annotation harboring the most associ-
ation with a given trait. However, the DMRs enriched
for association with schizophrenia tended to localize in
intronic regions (Additional file 1: Figure S4), which is
in agreement with the expectation that methylation re-
gions should not be localized in exons and UTRs. This
shows that using more information to label some gen-
omic regions in greater detail, such as potential regula-
tory regions in introns, might give a more precise
annotation of regions of association.
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Despite the genetic overlap between bipolar disorder
and schizophrenia, we do not find evidence of enrich-
ment of association of DMRs with bipolar disorder ei-
ther at the SNP level (Fig. 1, Additional file 1: Figure S1)
or the gene level (data available on request). This could
possibly be due to lack of sufficient power in the bipolar
disorder GWAS [34]. Additionally, the gene-level ap-
proach utilized by INRICH depicts enrichment of associ-
ation of human DMRs with height (Additional file 1:
Figure S5). This evidence is lacking at the SNP level as
depicted by QQ plots (Fig. 1, Additional file 1: Figure
S1). We speculate that this could be due to the differ-
ence in testing DMR-localized SNPs compared to genes
flanking human DMRs.
Although the DMRs utilized here were obtained from
bone samples, Gokhman et al. [29] assert that the DMRs
refer to species-specific methylation differences and not
tissue-specific variations [43]. Similarly, Hernando-
Herraez et al. [44] noted that species-specific DMRs
tend to be conserved across tissues and as such should
not represent tissue-specific variations. Other studies
also showed that neurological systems were enriched for
methylation differences even when the tissue samples
analyzed were not neurological [45–47]. Therefore, we
believe that our results are valid for a ‘brain’ phenotype
even though the DMRs were derived from non-brain tis-
sues. The enrichment seen for schizophrenia also cor-
roborates the results of Gokhman et al. [29] who
reported that DMRs were more enriched around genes
implicated in the nervous system amongst all the organ
systems tested for evolutionary changes in methylation
patterns. Hernando-Herraez et al. [44] also found that
methylation differences between humans and great apes
were located around genes controlling neurological and
developmental features. It is therefore possible that the
methylation differences were mediated by evolution of
genomic regions controlling neurodevelopmental pro-
cesses. The results of pathway analysis are consistent
with this. Both the DMR and NSS regions that are
enriched for association with schizophrenia contain
genes that are overrepresented in ‘CREB signaling in
neurons’ and ‘Synaptic long term potentiation’.
Our results hint that epigenomic evolution has taken
place in genomic regions implicated in the aetiology of
schizophrenia. Furthermore, these regions harbor
markers that are involved in the regulation of various
neurodevelopmental pathways. The fact that methylation
changes also took place in these very same regions sug-
gests a complex gene-by-environment interaction in the
evolution of humans, especially for pathways that led to
the development of our brain. While it is known that
various factors from the environment can make long-
lasting changes in DNA methylation patterns that can be
subsequently inherited at a population level [30, 31, 48],
the true significance of our findings from an evolutionary
standpoint suggests that the superior mental abilities of
our species may in part have been driven by environmen-
tal factors during the past 300,000 years [49, 50].
It is difficult to put an exact date on the emergence of
the superior mental abilities that define the modern
Homo sapiens. Anthropologists often date the onset of
the advanced intellectual abilities of Homo sapiens from
about 70,000 years onwards [51], a period which saw the
emergence of art, religion [52, 53] and possibly spoken
language [54]. From an evolutionary perspective, it sug-
gests a massive leap in the animal kingdom because
Homo sapiens became the first species not only to de-
velop the capacity to think and imagine things that do
not exist [52, 53], but also to communicate these ideas
to other members of the species [54]. This ability would
have been critical for effective coordination and cooper-
ation within large groups and may even have been
needed to keep a group together [55, 56]. The genomic
approach to analyze mental disorders used in the present
study and other studies can interrogate the effect of
changes which appeared in the last 300,000 years [49, 50],
but it will clearly be interesting to trace mores recent
changes. If a similar method used in the reconstruction of
Neanderthal and Denisovan genomes [29, 57] could be
implemented on samples of ancient Homo sapiens from
different time periods [58–65], then theoretically it should
be possible to reconstruct the methylomes and regions of
recent evolution from ancient humans [66]. Subsequently,
more detailed ‘time-course’ analyses of changes in methy-
lation patterns and in other regions of recent evolution
and their implications in schizophrenia will surely result
in more detailed elucidation of the evolutionary hypoth-
esis of schizophrenia. This is the promise of the novel
field of paleoepigenetics that seeks to infer past envir-
onmental cues that affected the epigenomes of an-
cient individuals [42, 43].
Conclusions
In summary, we have demonstrated that human gen-
omic regions whose methylation status was altered dur-
ing evolution are enriched in markers that show
association with schizophrenia. Our results concur with
previous genomic studies demonstrating that methyla-
tion changes in Homo sapiens have had the greatest im-
pact on the nervous system and provide evidence that
epigenomic evolution plays a role in conferring a high
risk of schizophrenia on humans. Future research should
attempt to perform a finer temporal resolution of the or-
igins of psychosis through the prism of evolutionary epi-
genomics. To explore the period of evolution before the
Homo lineage, it would also be interesting to determine
whether methylation signatures from primates are
enriched for schizophrenia markers. Future research
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should also investigate the influence of human-specific
DMRs on height.
Methods
Differentially methylated region data
Coordinates for DMRs were obtained from data publicly
available in Supplementary Table S2 of Gokhman et al.,
2014 [29]. This file contained DMRs inferred by compar-
ing genome sequence of fossilized Neanderthal and
Denisovan limb samples with methylation data from os-
teoblasts of modern humans. From the genomes of the
Neanderthal and Denisovan samples, Gokhman et al. in-
ferred methylation by utilizing the natural degradation
of methylated cytosine (C) to thymine (T) to create a
C→T ratio [29]. The methylation information, in the
form of C→T ratio, was then compared with each of the
three species and classified according to the hominid in
which the methylation change occurred, i.e. human-
specific, Neanderthal-specific and Denisovan-specific
DMRs. These DMRs do not represent tissue-specific
methylation but species-specific methylation [29]. The
human-specific DMRs comprise regions that have both
gained and lost methylation in comparison to Neander-
thal- and Denisovan-specific DMRs. DMRs that could
not be classified reliably in any of the three species (un-
classified DMRs) [29] were not used. Full methodo-
logical details for assigning DMRs are in the Additional
file of the original paper [29].
HAR data
Genomic coordinates were obtained from publicly avail-
able data (docpollard.com/2x) for three classes of human
accelerated region: HARs, in which regions conserved in
mammals are accelerated in humans; PARs, in which re-
gions conserved in mammals are accelerated in primates;
and pHARs, in which regions conserved in primates
(but not other mammals) are accelerated in humans.
Conversion to hg19 assembly was performed using the
liftOver tool from the UCSC Genome Browser.
NSS data
NSS data was obtained as a list of markers with corre-
sponding NSS values from Srinivasan et al. [19]. Markers
with negative values, indicating positive selection in
humans, were filtered out and used for analysis.
GWAS data
Summary statistics from GWAS of 12 common traits
were obtained from published datasets: schizophrenia
(SCZ) [14], bipolar disorder (BPD) [34], attention deficit
hyperactivity disorder (ADHD) [35], rheumatoid arthritis
(RA) [36], blood lipid markers (high density lipoprotein
(HDL), low density lipoprotein (LDL), triglycerides (TG),
total cholesterol (TC)) [37], blood pressure (systolic
blood pressure (SBP), diastolic blood pressure (DBP))
[38], body mass index (BMI) [39], and height [40]. For
studies published with hg18 coordinates (BPD, SBP, DBP,
HDL, LDL, TG, TC, ADHD, RA), conversion to hg19
was performed using the command line version of the
liftOver tool from the UCSC Genome Browser (http://
hgdownload.cse.ucsc.edu/downloads.html#utilities_
downloads). For BMI and height SNPs, the genomic co-
ordinates were obtained by mapping them to the assem-
bly of 1000 Genomes Project Phase 1 reference panel
SNPs [67].
SNP assignment to DMRs
SNPs were assigned to DMRs with LDsnpR [68] using
positional binning and LD (linkage disequilibrium)-
based binning in R [69]. We used both methods because
DMR-localized SNPs that were not genotyped in a spe-
cific GWAS would be missed if we used positional bin-
ning alone [68] (Additional file 1: Table S1). The LD file
utilized in HDF5 format was constructed on the Euro-
pean reference population of 1000 Genomes Project and
can be publicly downloaded at: http://services.cbu.uib.
no/software/ldsnpr/Download.
Enrichment analyses with stratified quantile-quantile (QQ)
plots
QQ plots are an effective tool to visualize the spread of
data and any deviations from the expected null distribu-
tions. They are frequently utilized in GWAS to depict
enrichment of true signals. When the observed distribu-
tion of data matches the expected distribution, there is a
lack of enrichment and a line of equality is obtained that
depicts the null hypothesis. A distribution such as this
reflects no enrichment of observed over expected data
distribution. However, if the observed and expected dis-
tributions differ, there will be deviation from this null
line. As described in detail by Schork et al. [32], left-
wards deflections from this null line represent enrich-
ment. The higher the leftward deflection, the greater is
the enrichment of true signals. In GWASs, due to the
extremely low p-values of SNPs, it is common to depict
p-values by converting them to negative log10 values so
that smaller p-values give higher negative logarithmic
values. We plotted the negative log10 of the observed p-
values of SNPs against the expected negative log10 of a
normal distribution. The distributions were corrected
for genomic inflation by λGC. This method of enrich-
ment was used to show for example [32] that specific
genomic regions are enriched for trait-associated SNPs
and are much more likely to associate with a given trait
than SNPs distributed across a genome. In other words,
when SNPs are stratified according to specific genomic
regions, there is a greater enrichment of true signals
than what is observed in the GWAS. Using a similar
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approach, we binned SNPs that fall in DMR regions and
plotted the stratified p-value distribution.
Enrichment analyses with INRICH
The stratified QQ plots are a useful visual tool for ob-
serving the presence or absence of enrichment of true
signals in a given set of SNPs. However, to quantify the
enrichment visually observed, we used the INterval En-
RICHment Analysis (INRICH) tool. It is a robust bio-
informatics pipeline to determine enrichment of
genomic intervals implicated by LD with predefined or
custom gene sets [33]. It takes into account several po-
tential biases that can otherwise lead to false positives. It
is well suited for testing GWAS-implicated SNPs for as-
sociation with gene sets as it controls for variable gene
size, SNP density, LD within and between genes, and
overlapping genes with similar annotations. We followed
the procedure described by Xu et al. [18], with the ex-
tended MHC region (chr6:25-35 Mb) masked and SNPs
with minor allele frequency (MAF) < 0.05 excluded. Full
details may be found in Additional file 1.
Pathway analysis
Pathway analysis was performed using Ingenuity Path-
way Analysis (IPA) from QIAGEN (https://www.qiagen.
com/no/shop/analytics-software/biological-data-tools/in-
genuity-pathway-analysis/, last accessed 26th August
2016). The reference set was Ingenuity Knowledge Base
(Genes). Both direct and indirect relationships were ana-
lyzed. All data sources were included with the confi-
dence parameter set to experimentally observed and
highly predicted pathways for Human. Under ‘Tissues &
Cell Lines’, we performed the analysis once with all
organ systems and once with only the nervous system.
5338 enriched DMR SNPs in 329 enriched DMRs (Add-
itional file 3) were mapped to 349 unique RefSeq genes
and 446 RefSeq genes in LD using the method of Schork
et al. [32]. Genes in LD blocks containing enriched NSS
markers were determined in a similar manner. 4276
enriched NSS markers mapped to 648 overlapping
RefSeq genes and 1363 RefSeq genes in LD. IPA was
performed on these gene lists.
Additional Files
Additional file 1: Additional Method, Figures and Tables (DOCX 475 kb)
Additional file 2: Annotation of all DMRs with schizophrenia-associated
SNPs. This file contains annotation of all the human-lineage specific DMRs
that are associated with schizophrenia markers. Details of the various
markers present within each DMR is provided, along with the marker with
most significant p-value. (XLSX 263 kb)
Additional file 3: Annotation of enriched DMRs with genes, promoters,
CpG islands and enhancers. This file contains detailed annotation of
those human-lineage specific DMRs that are enriched for association with
schizophrenia markers (except those in the MHC region). Compared to
Additional file 2, these DMRs represent those that are enriched and
whether they are present in any genes, promoters, enhancers or CpG
islands. (XLSX 26 kb)
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